Clinical Trial Update: Myo-inositol Versus Metformin Administration in Post-menopausal Women With Metabolic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing myo-inositol with metformin in post-menopausal women with metabolic syndrome; current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Myo-inositol (myo-inositol)
• metformin (metformin)

Snippet

Sponsor: University of Messina | Conditions: Metabolic Syndrome | Phase 2 | Status: UNKNOWN